Atlas Trials

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

Clinical trial NCT05362682 · UNKNOWN

Trial details

NCT number
NCT05362682
Sponsor
International Vaccine Institute
Status
UNKNOWN
Study type
OBSERVATIONAL
Sars-CoV-2 Infection
Start date
2022-02-24
Primary completion
2024-02-28
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.